BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36586096)

  • 1. Lacunes may worsen cognition but not motor function in Parkinson's disease.
    Chen K; Jin Z; Fang J; Qi L; Liu C; Wang R; Su Y; Yan H; Liu A; Xi J; Fang B
    Brain Behav; 2023 Feb; 13(2):e2880. PubMed ID: 36586096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cerebral small vessel disease burden and its imaging markers on gait, postural control, and cognition in Parkinson's disease.
    Chen K; Jin Z; Fang J; Qi L; Liu C; Wang R; Su Y; Yan H; Liu A; Xi J; Wen Q; Fang B
    Neurol Sci; 2023 Apr; 44(4):1223-1233. PubMed ID: 36547777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease.
    Chen H; Wan H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Feng T; Wang Y
    Parkinsonism Relat Disord; 2021 Feb; 83():86-92. PubMed ID: 33493785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of small vessel disease burden and lacunes on gait/posture impairment in Parkinson's disease.
    Chen H; Zhang M; Liu G; Wang X; Wang Z; Ma H; Pan Y; Wang D; Wang Y; Feng T
    Neurol Sci; 2020 Dec; 41(12):3617-3624. PubMed ID: 32458249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.
    Park YW; Shin NY; Chung SJ; Kim J; Lim SM; Lee PH; Lee SK; Ahn KJ
    Mov Disord; 2019 Nov; 34(11):1672-1679. PubMed ID: 31322758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between enlarged perivascular spaces and cognitive impairment in Parkinson's disease and vascular parkinsonism.
    Tu Y; Zhuo W; Peng J; Huang R; Li B; Liu Y; Zhang C; Zeng X; Huang L
    BMC Neurol; 2022 Jul; 22(1):282. PubMed ID: 35906550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
    Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study.
    Camarda C; Torelli P; Pipia C; Battaglini I; Azzarello D; Rosano R; Ventimiglia GD; Sottile G; Cilluffo G; Camarda R
    Curr Alzheimer Res; 2018; 15(11):1013-1026. PubMed ID: 29962342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of small vessel disease on motor and cognitive function in Parkinson's disease.
    Shibata K; Sugiura M; Nishimura Y; Sakura H
    Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
    Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
    Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study.
    Benisty S; Gouw AA; Porcher R; Madureira S; Hernandez K; Poggesi A; van der Flier WM; Van Straaten EC; Verdelho A; Ferro J; Pantoni L; Inzitari D; Barkhof F; Fazekas F; Chabriat H;
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):478-83. PubMed ID: 19211595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacunes and type 2 diabetes mellitus have a joint effect on cognitive impairment: a retrospective study.
    Zhou H; Hu J; Xie P; Dong Y; Chen W; Wu H; Jiang Y; Lei H; Luo G; Liu J
    PeerJ; 2022; 10():e13069. PubMed ID: 35261824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.
    Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; Rueckert D; Barkhof F; Scheltens P; Schmidt R; Fazekas F; Madureira S; Verdelho A; Wallin A; Wahlund LO; Waldemar G; Chabriat H; Hennerici M; O'Brien J; Inzitari D; Lötjönen J; Pantoni L; Erkinjuntti T
    Stroke; 2020 Jan; 51(1):170-178. PubMed ID: 31699021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.